重组Anti-MLKL抗体[3H1]
Anti-MLKL antibody [3H1]
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(47 Publications)
Rat Recombinant Monoclonal MLKL antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 47 publications.
查看别名
Mixed lineage kinase domain-like protein, hMLKL, MLKL
- WB
Supplier Data
Western blot - Anti-MLKL antibody [3H1] (AB243142)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lanes 1-3 : 5 secs; Lanes 4/5/7 : 3 secs; Lane 6 : 15 secs.
All lanes:
Western blot - Anti-MLKL antibody [3H1] (ab243142) at 1/2000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell), whole cell lysate at 10 µg
Lane 2:
HT-29 (human colorectal adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 4:
C6 (rat glial tumor glial cell), whole cell lysate at 10 µg
Lane 5:
RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate at 10 µg
Lane 6:
PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 10 µg
Lane 7:
NIH/3T3 (mouse embryonic fibroblast), whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rat IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rat-igg-h-l-hrp-ab205720'>ab205720</a>) at 1/2000 dilution
Predicted band size: 54 kDa
false
不同偶联物与剂型 (1)
-
Anti-MLKL antibody [3H1] - BSA and Azide free
反应性数据
产品详情
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The MLKL protein acts as an executioner of cell death by forming a complex that disrupts the plasma membrane integrity. This process is downstream of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) which phosphorylates MLKL to form the active necrosome complex. Active MLKL oligomerizes and migrates towards the inner leaflet of the plasma membrane binding to phosphatidylinositol phosphates which assists in pore formation and cellular rupture. The ability to measure MLKL activity levels such as via MLKL ELISA kits is important for understanding necrotic processes in detailed studies.
Pathways
MLKL is integrally involved in the necroptotic pathway alongside RIPK1 and RIPK3 which are key initiators of necroptosis. Phosphorylated MLKL acts downstream of RIPK3 resulting in cell death without caspase activation distinguishing necroptosis from apoptosis. MLKL and RIPK3 are tightly linked within this pathway with MLKL phosphorylation serving as a vital event for the execution phase. The necroptosis pathway is part of larger networks including inflammatory response pathways highlighting the importance of MLKL's role beyond sheer cell death.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (47)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules 15: PubMed40563424
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 21:e1013167 PubMed40359428
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 44:2424-2445 PubMed40128366
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:2772-2789 PubMed40064624
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 12:1521729 PubMed40061378
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Tohoku journal of experimental medicine : PubMed39938906
2025
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 292:1972-1990 PubMed39827378
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2024:1995952 PubMed39669913
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 56:1537-1548 PubMed39314165
2024
Applications
Unspecified application
Species
Unspecified reactive species
Renal failure 46:2403649 PubMed39311631
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com